Antiprotozoal and antihelminthic drugs (3) Flashcards
important protozoons
- Plasmodium strains → malaria
- Entamoeba hystolitica
- Trichomonas vaginalis
- Giardia lamblia
- Toxoplasma gondii
- Trypanosoma strains
- Leishmania strains
drugs used for malaria
- Chloroquine
- Mefloquine
- (Cinchona alkaloids), quinine!! (and quinidine)
(4. Halofantrine) - Lumefantrine
- Primaquine
(7. Inhibitors of folate synthesis
Sulfadoxine + pyrimethamine ) - Proguanil
- Atovaquone
- Antibiotics
doxycycline, clindamycin, azithromycin - (artemisinin (natural compound- NOBEL prize) and its derivatives:) arthemeter !!!, (artemotil, artesunat, dihydroartemisinin)
malarone
Atovaquone + proguanil
Profilaxis of malaria
- Chloroquine- area without resistant P. falciparum
- Malarone- area with chloroquine-resistant P. falciparum
- Doxycycline- area with multidrug resistant P. falciparum
Tretament of malaria – overview- some therapeutical possibilities
• Chloroquine sensitive plasmodium strains:
– Chloroquine (if there is a P. vivax or P. ovale infection, Primaquine
follows Choloroquine)
• Uncomplicated infections with chloroquine resistant P. falciparum
– Quinine + Doxycycline or Clindamycine
– Artemisinine d.+ Mefloquine or Lumefantrine+Arthemeter
• Severe or complicated infections with P. falciparum:
– Artesunate (1+2 days) or Quinine, afterward Doxycycline or Clindamycine (7 days) or Artesunate + Mefloquine
Chloroquine
- blood schizonticid
– inhibits heme-polymerase, inhibits the inactivation of heme into hemozoin →heme accumulates→toxic for the protozoons - well absorbed orally, accumulates in the tissues, elimination half life - 4 days
Antacids decrease oral
bioavailability - Treatment + prophylaxis in areas without resistant strains of P. falciparum (1st-line agent)
- Treatment of P. vivax and P. ovale
Adverse effects: few – pruritus, GI symptoms, visual disturbances (rare, due to retina- and cornea deposits). Hemolysis in G6PD deficient persons. Auditory damage QT prolongation rash, headaches
Clinical indications: suppressive therapy and prophylaxis
P. falciparum is commonly resistant
Interfere with macrophages lysosomal pH → inhibit antigen catabolism and presentation
- Oral
- Long T1/2 - Vd↑↑
- Autoimmune diseases (RA, SLE)
*Hydroxychloroquine
Less toxic metabolite of chloroquine; in addition to the use as anti-malaria agent, may be used in autoimmune disorders including RA, SLE, and Sjogren syndrome
Mefloquine
- blood schizonticid. Effective for many chloroquine-resistant P. falciparum strains
- administrated only orally, slow absorbtion
Adverse effects:
- neuropsychiatric
- GI distress
- Skin rash
- Conduction abnormalities
- Neurotoxicity (seizures)
Clinical indications: - for profilaxis in the case of known chloroquine resistancy, because of the adverse effects, less and less common
- therapy of uncomplicated malaria in combination with Artesunat
- Treatment + prophylaxis in areas with resistant P. falciparum
(1st-line agent)
quinine
Cinchona alkaloids
- blood schizonticid
Inhibit protozoal DNA
replication
- well absorbed orally, parenteral administration is also possible (slowly i.v. if severe infection)
Adverse effects:
- quinine intoxication (cinchonism)
– vomit, diarrhoeia, visual and hearing disturbances,
- hypersensitive reaction
- overdose – cardiotoxicity
- Cinchonism (GI distress, headache, vertigo, blurred vision, tinnitus)
- Acute hemolysis in G6PD deficient patients
- Conduction abnormalities
- Teratogenic
Clinical indications: - P. falciparum malaria, last therapeutical option
- Not for profilaxis due to its toxicity
- Babesiosis
- Treatment of multidrug- resistant malaria
- May be used in combination with
doxycycline or clindamycin
*Quinidine
Antiarrhythmic agent, isomer of quinine; can be used IV in the treatment of severe complicated P. falciparum malaria Adverse effects include cinchonism, QRS and QT prolongation with risk of syncope
- Muscarinic receptor inhibition – HR and AV conduction ↑
- May cause vasodilation via α inhibition (potential reflex tachycardia)
- Enhanced effects under hyperkalemia
- Displaces digoxin from tissue binding sites (enhancing toxicity)
- Weak base – antacids increase its absorption (increasing toxicity)
- Oral
- Wide clinical use in many arrhythmias
Quinidine is occasionally used as a class Ia antiarrhythmic agent to prevent ventricular arrhythmias, particularly in Brugada Syndrome, although its safety in this indication is uncertain. It reduces the recurrence of atrial fibrillation after patients undergo cardioversion, but it has proarrhythmic effects and trials suggest that it may lead to an overall increased mortality in these patients. Quinidine is also used to treat short QT syndrome
Halofantrine
not on the list
- blood schizonticid for all plasmodium forms. - good oral absorbtion
Adverse effects: GI, rashes, pruritus
arrhythmia, impulse conduction disturbances!
Clinical indications: rarely used because of its toxicity
Lumefantrine
Similar to Halofantrine with less side effects.
Indicated in combination with arthemeter for the treatment of not complicated P. falciparum malaria
Halofantrine:
- blood schizonticid for all plasmodium forms. - good oral absorbtion
Adverse effects: GI, rashes, pruritus
arrhythmia, impulse conduction disturbances!
QT prolongation
Clinical indications: rarely used because of its toxicity
Primaquine
- tissue schizonticid for all types of plasmodium strains. -
- Tissue schizonticide
(kill schizonts in the liver) - Metabolites act as oxidants
- Eradication of liver stages of P. vivax and P. ovale
- Used in combination with chloroquine (or other blood schizonticide)
Adverse effects: - well tolerated; - in higher doses GI side effects, - very rarely leukocytopenia, - methemoglobinaemia, - hypersensitive reaction - GI distress - Rash, headaches - Acute hemolysis in G6PD deficient patients - Teratogenic
only oral administration
Clinical indications: - radical cure of acute Vivax and Ovale malaria - for prophylaxis of all types of malaria strains
- pneumocystis jiroveci infection (in combination with clindamycine)
Sulfadoxine + pyrimethamine
not on the list?
Inhibitors of folate synthesis
Clinical indications:
- In case of Chloroquine resistancy, treatment of uncomplicated malaria - P. falciparum is commonly resistant
Proguanil
- biguanid derivative
- its active metabolite inhibits the bifunctional dihydrofolate reductase thymidylate synthase → inhibits DNA synthesis
- Oral
- Prodrug
- Generally well-tolerated
→ antimetabolite (folate synthesis ↓)
- Malaria prophylaxis (with atovaquone)
Atovaquone/Proguanil (Malarone) - Atovaquone → disrupts mitochondrial metabolism
- Proguanil → antimetabolite (folate synthesis ↓)
- Oral
- Treatment + prophylaxis of multidrug-resistant
P. falciparum malaria - Generally well-tolerated
- GI distress, fever, rash
Atovaquone
- inhibits mitochondrial functions
- tissue and blood schizonticid
Clinical indications:
atovaquone + proguanil → for treatment and prophylaxis in case of known chloroquine resistancy (P. falciparum is usually susceptible)
atovaquon → alternative compound in pneumocystis jiroveci infection
Antibiotics used in malaria
doxycycline, clindamycin, azithromycin
arthemeter
artemisinin (natural compound- NOBEL prize) and its derivatives: arthemeter (artemotil, artesunat, dihydroartemisinin)
- blood schizonticid (fast effect). They might act through production of free radicals.
- Production of free radicals
within the plasmodium food vacuoles - possible ways of administration: orally, i.v., i.m.
T1/2 too short to be used as prophylaxis
Adverse effects: well tolerated (!), most common GI side effects (nausea, diarrhea, vomiting)
Clinical indications:
• often used for the treatment of falciparum malaria
• oral combinations: Artesunate-mefloquine, Artemether-lumefantrine
- Treatment of multidrug- resistant malaria
- Effective against quinine- resistant strains
Antiprotozoal treatment; drugs action ….
Tissue schizonticids : act on liver forms, e.g. primaquine
Blood schizonticids
(suppressive therapy) : act on erythrocyte forms, prevents the clinical symptoms e.g. chloroquine, quinine, most of them
both: atovaquone
gametocides : killgametocytes,e.g. primaquine
prophylactic therapy
Amebiasis
Parasitic infection of the intestines is known as Amebiasis
Signs and symptoms:
- Patient has loose Stools
- Stomach pain
- Amebic Dysentery
- Fever and Tenderness
- Abscess
Treatment:
(iodoquinol, Diloxanid furoat, tinidazole, Paromomycin (aminoglycoside),)
Metronidazole
Iodoquinol
Diloxanid furoat
Paromomycin
(not on the list)
Iodoquinol
poor absorbtion given orally, mainly GI adverse effects
Clinical indications:
- in monotherapy for the treatment of intestinal asymptomatic amebiasis
- in combination for the treatment of intestinal or extraintestinal amebiasis
Diloxanid furoat
Adverse effects: GI
Clinical indications: alternative compound in asymptomatic amebiasis
Paromomycin (aminoglycoside)
Mechanism of action: inhibits protein synthesis
Clinical indications: second line drug in intestinal and extraintestinal infections
TREATMENT OF AMEBIASIS